Clinical Trial of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy

Condition:   Peripheral Neuropathy Interventions:   Other: Manual acupuncture;   Other: Electro-acupuncture Sponsor:   Case Comprehensive Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) occurs in approximately 30% to 40% of patients who receive chemotherapy; however, standardized treatment for CIPN has not yet been developed. Acupuncture is widely used to treat CIPN in Korea, but its efficacy has not been investigated. The purpose of this study is to review the current literature on the efficacy of acupuncture and electroacupuncture (EA) in treating CIPN. Materials and Methods: We will perform a literature review using the relevant databases, including MEDLINE, Embase, the Allied and Complementary Medicine Databases (AMED), and China Nat...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
Condition:   Peripheral Neuropathy Interventions:   Other: Manual acupuncture;   Other: Electro-acupuncture Sponsor:   Case Comprehensive Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSION: the use of acupuncture appears to be associated with an improvement in the symptoms of chemotherapy-induced peripheral neuropathy and has no side effects. In order to improve the evidence about benefits associated with acupuncture, more experimental studies using both subjective and objective measures are needed. PMID: 30916227 [PubMed - in process]
Source: Revista Latino-Americana de Enfermagem - Category: Nursing Authors: Tags: Rev Lat Am Enfermagem Source Type: research
Conclusions: Acupuncture improved symptoms of CIPN and QoL in Korean women suffering from peripheral neuropathy after chemotherapy using taxane for breast cancer. The effects of acupuncture lasted for at least 1 month after the treatment. PMID: 30420895 [PubMed]
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
This study is a single-center, randomized, placebo-controlled trial with two parallel groups and a 2-week follow-up. We will enroll 80 breast cancer patients who are newly diagnosed with CIPN after chemotherapy. Duloxetine or pregabalin will be prescribed to all participants from the initial assessment. Half of the patients will be assigned into the experimental group and the other half to the control group. The CarebandR (Piomed Inc., Seoul, Korea), a wearable wristband that generates low-frequency electrostimulation, will be administered only to the experimental group. Electrostimulation will be administered on the unila...
Source: Trials - Category: Research Source Type: clinical trials
Publication date: August 2018Source: Journal of Acupuncture and Meridian Studies, Volume 11, Issue 4Author(s): A. Poini, A. Pavesi, S. Magno, C. Maggiore, C. Zamagni, D. Rubino, M. Devecchi, G.M.G. Farella, U. Mazzanti, D. Trevisan, C.M. Giovanardi
Source: Journal of Acupuncture and Meridian Studies - Category: Complementary Medicine Source Type: research
Condition:   Acupuncture , Chemotherapy-induced Peripheral Neuropathy Intervention:   Procedure: acupuncture Sponsor:   China Medical University Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acupuncture | Brain | Cancer & Oncology | Chemotherapy | Clinical Trials | Neurology | Peripheral Neuropathy | Research